L29 Antivirals Flashcards

1
Q

Enfuvirtide disease

A

HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Enfuvirtide path

A

blocks refolding of gp41

Inhibits membrane fusion for ENTRY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amantadine disease

A

infuenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Amantadine path

A

blocks M2 ion channel

preventing nucleocapsid release at end of ENTRY (uncoating)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rimantadine disease

A

influenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rimantadine path

A

blocks M2 ion channel

preventing nucleocapsid release at end of ENTRY (uncoating)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acyclovir disease

A

herpes

Most effective against HSV1,2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acyclovir type

A

nucleoside analogue preventing REPLICATION (nucleic acid synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acyclovir specificity depends on

A

Virus thymadine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ganciclovir disease

A

CMV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Gangciclovir vs Acyclovir

A

Works on CMV but more toxic due to cellular kinases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Valganciclovir vs Acyclovir

A

Both treat HSV but has improved bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acyclovir hurdles

A

Bioavailability

Specificiity on virus Thymadine Kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Foscarnet disease

A

Herpes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Foscarnet path

A

Prevent viral polymerase activity preventing REPLICATION (nucleic acid synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Foscarnet downfalls

A

IV administration

Toxic

17
Q

Nucleoside inhibitors for HIV and HepB negatives

A

Toxic
Resistance
Usually includes more than one

18
Q

Ribavarin disease

A

RNA viruses

19
Q

Ribavarin mechanisms

A

Triphosphate inhibits polymerase
Monophasphate inhibits inosine monophosphate dh
Impaires capping of mRNA

20
Q

Ritonavir disease

A

HIV

21
Q

Ritonavir path

A

Block Gag-Pol cleavage
Boosts protease inhibitors
Prevents PROTEASE (late protein processing)

22
Q

How to prevent virus release

A

Neuraminidase inhibitors

23
Q

Bioavailability components

A

Absorption into body
Transport to site
Intake by cell
Half life

24
Q

Neuraminidase inhibitor disease

A

Influenza..virus release

25
Q

Interferons are more effective against ___ than ____

A

RNA viruses than DNA viruses

26
Q

Killed vaccine disadvantages

A

does not induce cell mediated immunity
protection is shorter
usually injected

27
Q

Polio vaccine complication

A

Vaccine acquired paralytic poliomyelitis VAPP

We only use the killed vaccine

28
Q

Immune cells important for vaccination

A

B cells
CD8 T-cells
CD4 T-cells

29
Q

Vaccines utilizing B cells only

A
pneumonococcal
Influenza B (HIB)
30
Q

Vaccines utilizing B and T cell including ____

A

Including IgA
Influenza
Polio
Oral typhoid